Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Tax Provisions: 2010-2013

Historic Tax Provisions for Cytokinetics (CYTK) over the last 2 years, with Sep 2013 value amounting to -$26,000.

  • Cytokinetics' Tax Provisions was N/A to -$26,000 in Q3 2013 from the same period last year, while for Sep 2013 it was -$104,000, marking a year-over-year change of. This contributed to the annual value of -$272,124 for FY2010, which is 215.81% down from last year.
  • According to the latest figures from Q3 2013, Cytokinetics' Tax Provisions is -$26,000, which was down 0.00% from -$26,000 recorded in Q2 2013.
  • In the past 5 years, Cytokinetics' Tax Provisions registered a high of $234,116 during Q1 2010, and its lowest value of -$272,888 during Q3 2010.
  • Over the past 3 years, Cytokinetics' median Tax Provisions value was -$26,000 (recorded in 2013), while the average stood at -$28,234.
  • Within the past 5 years, the most significant YoY rise in Cytokinetics' Tax Provisions was 90.47% (2011), while the steepest drop was 117.78% (2011).
  • Cytokinetics' Tax Provisions (Quarterly) stood at -$272,888 in 2010, then surged by 90.47% to -$26,000 in 2011, then spiked by 37.55% to -$26,000 in 2012, then reached -$26,000 in 2013.
  • Its Tax Provisions was -$26,000 in Q3 2013, compared to -$26,000 in Q2 2013 and -$26,000 in Q1 2012.